A rapid HIV testing program for labor and delivery in an inner-city teaching hospital

AIDS Reader

Volumn 16, Issue 1, 2006, Pages

  Aaron, Erika ^a   Levine, Amy B ^b   Monahan, Keri ^c   Biondo, Charles P ^d  

^a Women's Services   (United States)

^b Department of Obstetrics and Gynecology ^*

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

HIV AIDS; Pregnancy; Rapid HIV Testing; Vertical transmission

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; VIRUS ANTIBODY; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; NEWBORN; PREGNANCY; PREMATURE LABOR; PROPHYLAXIS; TEACHING HOSPITAL; VIRUS DETECTION; VIRUS TRANSMISSION; ALGORITHM; DELIVERY; DISEASE TRANSMISSION; DRUG ADMINISTRATION; LABOR; PREGNANCY COMPLICATION; TIME; UNITED STATES; URBAN POPULATION;

ALGORITHMS; ANTI-HIV AGENTS; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HOSPITALS, TEACHING; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TIME FACTORS; UNITED STATES; URBAN POPULATION; ZIDOVUDINE;

EID: 33644833673     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal transmission. J Acquir Immune Defic Syndr. 2002;29:484-494.
2. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR. 2001;50:59-86.
3. Office of Inspector General, Health and Human Services. Reducing obstetrician barriers to offering HIV testing. Washington, DC: Department of Health and Human Services; March 2002. OEI-05-01-00260.
4. American College of Obstetricians and Gynecologists. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. ACOG Committee Opinion 304. Washington, DC: ACOG; 2004.
5. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-testing during labor. JAMA. 2004;292:219-223.
6. Centers for Disease Control and Prevention. Rapid HIV-1 Antibody Testing during Labor and Delivery for Women of Unknown HIV Status: A Practical Guide and Model Protocol. January 30, 2004.
7. Connor EM, Sperling RS, Gelber R. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
8. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2002. Natl Vital Stat Rep. 2003;52:1-113.
9. Lindsay MK, Feng TI, Peterson HB, et al. Routine human immunodeficiency infection screening in unregistered and registered inner-city parturients. Obstet Gynecol. 1991;77:599-603.
10. Centers for Disease Control and Prevention. Division of HIV/AIDS Prevention. Rapid HIV testing of women in labor and delivery. Updated June 18, 2003.
11. Wade N, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of human immunodeficiency virus. N Engl J Med. 1998;339:1409-1414.
12. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. February 24, 2005.
13. Cohen MH, Olszewski Y, Branson B, et al. Using point-of-care testing to make rapid HIV-1 tests in labor really rapid. AIDS. 2003;17:2121-2124.
14. Forsyth BWC, Barringer SR, Walls TA, et al. Rapid HIV testing of women in labor - too long a delay. J Acquir Immune Defic Syndr. 2004;35:151-154.
15. Stringer JSA, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost effectiveness analysis. Obstet Gynecol. 1999;94:34-40.
16. Mrus JM, Tsevat J. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care. Med Decis Making. 2004;24:30-39.